亮氨酸氨基肽酶

目的探讨尿亮氨酸氨基肽酶（LAP）筛查糖尿病和高血压病早期肾损害的临床价值。

Objective To study the role of urine leucine aminopeptidase ( LAP ) for sifting early renal injury in diabetic and hypertension patients .

亮氨酸氨基肽酶在肝病及癌症诊断中的应用

Application of leucine aminopeptidase in diagnosis of hepatic diseases and cancers

目的探讨血清丙氨酸氨基肽酶（AAP）和亮氨酸氨基肽酶（LAP）在肝胆疾病诊断中的应用价值。

Objective To compare clinical significance of alanine aminopeptidase ( AAP ) and leucme aminopeptidase ( LAP ) activity in serum for hepatobiliary disease .

对80例急性颅脑损伤患者脑脊液（CSF）肌酸磷酸激酶（CPK）、乳酸脱氢酶（LDH）、谷草转氨酶（GOT）和亮氨酸氨基肽酶（LAP）活性作了测定。

The activities of creatine phosphokinase ( CPK ) , lactic dehydrogenase ( LDH ) , glutamic oxaloacetic transaminase ( GOT ) and leucine aminopeptidase ( LAP ) in cerebrospinal fluid ( CSF ) were measured in 80 patients with acute head injury .

亮氨酸氨基肽酶测定对肝病的诊断

Significance of detecting serum leucine aminopeptidase activity in diagnosis of liver diseases